Investment Stage

Focus Areas

About Investor

Elizabeth Klein is an Investment Director at Calculus Capital, focusing on investments in Biotechnology and Health IT companies. She evaluates growth-stage businesses developing innovative healthcare technologies, digital health platforms, and life sciences solutions. Her investment activity primarily targets Series A and Series B companies, with Calculus Capital investing between $1M and $4M, averaging around $2M per investment. Elizabeth works with founders on commercial strategy, market expansion, and investment readiness. She is particularly interested in companies combining scientific innovation with scalable healthcare applications.